Please login to the form below

Not currently logged in
Email:
Password:

Austria

This page shows the latest Austria news and features for those working in and with pharma, biotech and healthcare.

Long-serving R&D head Bischofberger to leave Gilead

Long-serving R&D head Bischofberger to leave Gilead

Austria-born Bischofberger - who rose to prominence as one of the inventors of Roche’s big-selling influenza drug Tamiflu (oseltamivir) - will leave the company fully in July after 28 years

Latest news

  • Health coverage across state lines Health coverage across state lines

    In response, European centre-left, pro-EU political parties have seen an uptick in support, winning victories in Austria and the Netherlands.

  • Merck mulls sale of consumer health division Merck mulls sale of consumer health division

    5m tablet manufacturing facility for its consumer health unit in Spittal, Austria, boosting its production capacity by more than a third to 3 billion tablets a year.

  • Most of the EU would like to host the EMA Most of the EU would like to host the EMA

    Belgium, France, Germany, Ireland, Czech Republic, Luxembourg, Austria and Poland have all applied to host the banking body, however, member states will only be allowed to host either the EMA or ... Milan (Italy). Porto (Portugal). Sofia (Bulgaria).

  • Vertex strikes Italian reimbursement deal for Orkambi Vertex strikes Italian reimbursement deal for Orkambi

    The firm was light on the details of the deal, but said it would add to pricing European pricing and reimbursement agreements in Germany, Austria, Denmark, Ireland and Luxembourg.

  • Standing out in a crowd Standing out in a crowd

    Sponsored by the Norwegian government, the study involved nearly 500 patients across some 40 trial sites and was presented at the 2016 UEG Week in Vienna, Austria.

More from news
Approximately 1 fully matching, plus 119 partially matching documents found.

Latest Intelligence

  • Attracting doctors to low-demand specialties Attracting doctors to low-demand specialties

    project. This global programme attracted candidates from Austria, Belgium, Canada, China, France, Italy, the Netherlands, Taiwan, the UK and the USA.

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The alliance has subsequently expanded to include Luxembourg and Austria, with Ireland expected to be the next country to become a member.

  • Charting a course for expansion Charting a course for expansion

    Germany and the UK are first, Austria, Denmark and the Netherlands are right there with us - it's really their timing that determines it, not just ours.

  • Immunisation politicised Immunisation politicised

    Reshaping the HPV vaccine in Austria. While swift in other European countries, implementation took several years in Austria. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.

  • Safe from harm? Safe from harm?

    In Germany (75%), Austria (71%), Canada (66%), Finland (65%) and the US (64%), patients were most likely to work with the physician so that both of them have input into decision.

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics